Literature DB >> 25597700

Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen.

Jeffrey Harding1, Anna Ritter2, Aditya Rayasam3, Zsuzsanna Fabry1, Matyas Sandor4.   

Abstract

Granulomatous inflammation is characteristic of many autoimmune and infectious diseases. The lymphatic drainage of these inflammatory sites remains poorly understood, despite an expanding understanding of lymphatic role in inflammation and disease. Here, we show that the lymph vessel growth factor Vegf-c is up-regulated in Bacillus Calmette-Guerin- and Mycobacterium tuberculosis-induced granulomas, and that infection results in lymph vessel sprouting and increased lymphatic area in granulomatous tissue. The observed lymphangiogenesis during infection was reduced by inhibition of vascular endothelial growth factor receptor 3. By using a model of chronic granulomatous infection, we also show that lymphatic remodeling of tissue persists despite resolution of acute infection and a 10- to 100-fold reduction in the number of bacteria and tissue-infiltrating leukocytes. Inhibition of vascular endothelial growth factor receptor 3 decreased the growth of new vessels, but also reduced the proliferation of antigen-specific T cells. Together, our data show that granuloma-up-regulated factors increase granuloma access to secondary lymph organs by lymphangiogenesis, and that this process facilitates the generation of systemic T-cell responses to granuloma-contained antigens.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25597700      PMCID: PMC4305185          DOI: 10.1016/j.ajpath.2014.09.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  86 in total

Review 1.  LYVE-1, the lymphatic system and tumor lymphangiogenesis.

Authors:  D G Jackson; R Prevo; S Clasper; S Banerji
Journal:  Trends Immunol       Date:  2001-06       Impact factor: 16.687

2.  Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self.

Authors:  Je-Wook Lee; Mathieu Epardaud; Jing Sun; Jessica E Becker; Alexander C Cheng; Ai-ris Yonekura; Joan K Heath; Shannon J Turley
Journal:  Nat Immunol       Date:  2006-12-31       Impact factor: 25.606

3.  Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes.

Authors:  Veronika Lukacs-Kornek; Deepali Malhotra; Anne L Fletcher; Sophie E Acton; Kutlu G Elpek; Prakriti Tayalia; Ai-ris Collier; Shannon J Turley
Journal:  Nat Immunol       Date:  2011-09-18       Impact factor: 25.606

4.  Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.

Authors:  Jennifer L Taylor; Jessica M Hattle; Steven A Dreitz; JoLynn M Troudt; Linda S Izzo; Randall J Basaraba; Ian M Orme; Lynn M Matrisian; Angelo A Izzo
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 5.  Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.

Authors:  David G Jackson
Journal:  APMIS       Date:  2004 Jul-Aug       Impact factor: 3.205

6.  TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.

Authors:  Daniel R Roach; Andrew G D Bean; Caroline Demangel; Malcolm P France; Helen Briscoe; Warwick J Britton
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.

Authors:  Y Zhang; M Doerfler; T C Lee; B Guillemin; W N Rom
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

9.  Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism.

Authors:  Simona Podgrabinska; Okebugwu Kamalu; Lloyd Mayer; Motomu Shimaoka; Hans Snoeck; Gwendalyn J Randolph; Mihaela Skobe
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

10.  Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40.

Authors:  F Pedica; C Ligorio; P Tonelli; S Bartolini; P Baccarini
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

View more
  14 in total

1.  Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.

Authors:  N P Kumar; B Velayutham; D Nair; S Babu
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

2.  Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosis.

Authors:  Thomas R Lerner; Cristiane de Souza Carvalho-Wodarz; Urska Repnik; Matthew R G Russell; Sophie Borel; Collin R Diedrich; Manfred Rohde; Helen Wainwright; Lucy M Collinson; Robert J Wilkinson; Gareth Griffiths; Maximiliano G Gutierrez
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

Review 3.  Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?

Authors:  Benjamin Stump; Ye Cui; Pranav Kidambi; Anthony M Lamattina; Souheil El-Chemaly
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

Review 4.  Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?

Authors:  Gabriella R Abouelkheir; Bradley D Upchurch; Joseph M Rutkowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-07

5.  Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors.

Authors:  G R Kathamuthu; K Moideen; D Baskaran; G Sekar; S Rathinam; V J Bharathi; G R Ganeshan; S Babu
Journal:  Int J Tuberc Lung Dis       Date:  2018-05-01       Impact factor: 2.373

6.  Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Shanmugam Sivakumar; Pradeep A Menon; Vijay Viswanathan; Hardy Kornfeld; Subash Babu
Journal:  J Infect       Date:  2016-10-04       Impact factor: 6.072

7.  Inhibition of infection-induced vascular permeability modulates host leukocyte recruitment to Mycobacterium marinum granulomas in zebrafish.

Authors:  Julia Y Kam; Tina Cheng; Danielle C Garland; Warwick J Britton; David M Tobin; Stefan H Oehlers
Journal:  Pathog Dis       Date:  2022-04-29       Impact factor: 3.951

8.  Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling.

Authors:  Eric M Walton; Mark R Cronan; C J Cambier; Andrea Rossi; Michele Marass; Matthew D Foglia; W Jared Brewer; Kenneth D Poss; Didier Y R Stainier; Carolyn R Bertozzi; David M Tobin
Journal:  Cell Host Microbe       Date:  2018-10-10       Impact factor: 21.023

Review 9.  Current concepts in granulomatous immune responses.

Authors:  Melinda Herbath; Zsuzsanna Fabry; Matyas Sandor
Journal:  Biol Futur       Date:  2021-02-25

Review 10.  Neuroinflammation-Driven Lymphangiogenesis in CNS Diseases.

Authors:  Martin Hsu; Collin Laaker; Matyas Sandor; Zsuzsanna Fabry
Journal:  Front Cell Neurosci       Date:  2021-06-23       Impact factor: 6.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.